Granted Patent
B2
US 7,414,024 · App. 10/496,793 · Granted Aug 19, 2008
Proteins with IL-6 inhibiting activity
Assignees:
Universite Claude Bernard Lyon 1; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale - I.N.S.E.R.M.; Hospices Civils de Lyon
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The subject of the present invention concerns proteins with IL-6 inhibiting activity and thier use, and the use of proteins containing at least the amino acid seqeunce SEQ ID NO. 4 as medicianl product, in paritcular as anti-cancerous agent.
Claims (3)
1. An isolated protein consisting of the amino acid sequence of SEQ ID NO: 4.
2. A composition comprising a protein in association with a pharmaceutically acceptable excipient, said protein consisting of the amino acid sequence of SEQ ID NO: 4.
3. A composition according to claim 2 formulated for oral, sublingual, subcutaneous, intramuscular, intravenous, or topical administration.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 30, 2004
From: BLAY, JEAN-YVES; ALBERTI, LAURENT
To: UNIVERSITE CLAUDE BERNARD LYON 1; CENTRE LEON BERARD; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE I.N.S.E.R.M.; HOSPICES CIVILS DE LYON
Reel/Frame 016031/0485 →
Priority Claims (1)
FR 01 15623
· Dec 4, 2001
· national
Continuity (1)